13G Filing: Baker Bros. Advisors and Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

Page 2 of 10

Page 2 of 10 – SEC Filing

CUSIP No.    079481107

1.

NAMES OF REPORTING PERSONS

Baker Bros. Advisors LP

2.

CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a) ¨

(b)
¨

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER

5,032,313

6.

SHARED VOTING POWER

0

7.

SOLE DISPOSITIVE POWER

5,032,313

8.

SHARED DISPOSITIVE POWER

0

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON

5,032,313

10.

CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 

¨

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
9

15.2% (1)

12.

TYPE OF REPORTING PERSON (See Instructions)

IA, PN

(1) Based on 33,078,089 shares of common stock outstanding
as of March 31, 2017, based upon information obtained from the Issuer on April 10, 2017.

Page 2 of 10 Pages

Follow Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

Page 2 of 10